Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 3—March 2020
CME ACTIVITY - Research

Methicillin-Resistant Staphylococcus aureus Bloodstream Infections and Injection Drug Use, Tennessee, USA, 2015–2017

Meghana P. ParikhComments to Author , Rany Octaria, and Marion A. Kainer
Author affiliations: Tennessee Department of Health, Nashville, Tennessee, USA (M.P. Parikh, R. Octaria, M.A. Kainer); Vanderbilt University, Nashville (R. Octaria)

Main Article

Table 2

Prevalence of IDU-related diagnoses among patients with methicillin-resistant Staphylococcus aureus bloodstream infections, by IDU status, Tennessee, USA, 2015–2017*

Diagnosis IDU, no. (%), n = 1,839 Non-IDU, no. (%), n = 5,807 p value Overall, no. (%), n = 7,646
Endocarditis 743 (40.4) 626 (10.8) <0.001 1,369 (17.9)
Hepatitis C 932 (50.7) 377 (6.5) <0.001 1,309 (17.1)
Osteomyelitis/septic arthritis 516 (28.1) 1,340 (23.1) <0.001 1,856 (24.3)
Skin/soft tissue infection 863 (46.9) 2,227 (38.4) <0.001 3,090 (40.4)

*IDU, injection drug use.

Main Article

Page created: February 12, 2020
Page updated: February 12, 2020
Page reviewed: February 12, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external